More Than 200 Preventive Vaccines, Developed By Both Industry And Non-industry Players, Are Being Evaluated In Clinical Stages Of Development, Claims Roots Analysis

>

More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development, claims Roots Analysis

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in the development of immunological memory.

 

To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

 

The USD 94 billion (by 2030) financial opportunity within the global preventive vaccine market has been analyzed across the following segments:

  • Route of Administration
  • Intramuscular
  • Subcutaneous
  • Oral
  • Intravenous
  • Others

 

  • Type of Vaccine
  • Pneumococcal Conjugate Vaccine
  • Human Papilloma Virus Vaccine
  • Rotavirus Vaccine
  • Influenza Vaccine
  • MMR Vaccine
  • Tetanus and Diphtheria Booster Vaccine
  • Varicella Vaccine
  • DTaP-Hib-IPV Vaccine
  • DTaP-HepB-Hib-IPV Vaccine
  • Others

 

  • Type of Vaccine API
  • Live, Attenuated Vaccine
  • Inactivated Vaccine
  • Conjugate Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • Others

 

  • Target Patient Population
  • Pediatric Patients
  • Adults

 

  • Key Players
  • GlaxoSmithKline
  • Merck
  • Sanofi Pasteur
  • Pfizer
  • Emergent BioSolutions
  • CSL
  • Others

 

  • Key Geographical Regions 
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 

 

The Global Preventive Vaccines Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

  • Bio Farma
  • Emergent BioSolutions
  • GC Pharma
  • GlaxoSmithKline
  • Janssen
  • Merck
  • Novavax
  • Pfizer
  • Sanofi Pasteur
  • Valneva

 

Table of Contents

 

  1. Preface

    2. Executive Summary

  2. Introduction

  3. Market Landscape

  4. Company Competitiveness Analysis

  5. Company Profiles

  6. Clinical Trial Analysis

  7. Ongoing Vaccine Development Initiatives for Complex Conditions

  8. Funding and Investment Analysis

  9. Market Sizing and Opportunity Analysis

  10. Case-in-Point: Contract Manufacturing of Vaccines

  11. Concluding Remarks

 

  1. Executive Insights

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments

Other related blogs

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis

By : Roots Analysis

  Driven by the growing complexity of modern pharmacological interventions, industry stakehold..


Europe Blood Glucose Monitoring System Market – Forecast (2019-2026)

By : Maximize Market

Europe Blood Glucose Monitoring System Market is expected to reach USD XX Billion by 2026 from USD X..


Kara's Orchards CBD Gummies is the most refreshed thing

By : Vilopsha

Kara's Orchards CBD Gummies UK By and large, Kara's Orchards CBD Gummies is the most refreshed thing..